VentriPoint Diagnostics Ltd. VPT.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · ventripoint.com
VentriPoint Diagnostics Ltd. is a medical device company that develops and commercializes the Ventripoint Medical System (VMS), an AI-assisted cardiac imaging platform that generates three-dimensional models of heart chambers from standard ultrasound equipment. The company is headquartered in Toronto, Canada, and its technology is used for monitoring patients with congenital heart disease, pulmonary hypertension, and other cardiac conditions. VentriPoint received a Gold Medal at the 2026 Edison Awards in the Precision Health Technologies category.
Key ratios
FreeCashFlowOnSale TTM -9.55
FreeCashFlowOnSale 2024 -35.57
FreeCashFlowOnSale 2023 -77.32
FreeCashFlowOnSale 2022 -60.66
ReturnOnAssets TTM -4.24
ReturnOnAssets 2024 -2.36
ReturnOnAssets 2023 -0.78
ReturnOnAssets 2022 -0.4
ReturnOnEquity TTM -29.73
ReturnOnEquity 2023 -2.05
ReturnOnEquity 2022 -0.76
TotalRevenueYoYGrowth TTM 0.29
TotalRevenueYoYGrowth 2024 0.94
TotalRevenueYoYGrowth 2023 -0.28
Recent news
Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance
2026-06-15 · TheNewsWire